LMRI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $10.32
Market Cap (MRQ) $991M
Debt/Equity (MRQ) 1.4
52W Range $6–$19

LMRI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend LMRI 5Y avg Peer Median Verdict
P/B (MRQ) 1.6 · · ·
Price / Tangible Book (MRQ) 1.7 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -101.7%
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 12, 2026 $0.20 $0.16 24.1%
March 31, 2026 May 12, 2026 $0.18 $0.12 45.3%
Dec. 31, 2025 $-0.20 $0.07 -374.3%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Balance Sheet 20
Metric Trend 2025
Cash & Equivalents $59M
Prepaid Expense $18M
Current Assets $227M
PP&E (Net) $145M
Goodwill $808M
Intangibles $41M
Other Non-current Assets $44M
Total Assets $1.76B
Accounts Payable $45M
Current Liabilities $179M
Capital Leases $71M
Deferred Tax $41M
Other Non-current Liabilities $35M
Total Liabilities $1.18B
Long-term Debt $834M
Common Stock $96.0K
Retained Earnings $-631M
Stockholders' Equity $586M
Liabilities + Equity $1.76B
Shares Outstanding 96,109,927

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
No data for this statement

Not enough fundamentals data to build this statement yet.

Institutional owners (13F) 104 filers · $344.1M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 104
Value held $344.1M
New positions 31
Exited positions 17
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
31 (-16 vs prior Q) 17 (+1 vs prior Q) 31 (+9 vs prior Q) 28 (+13 vs prior Q) -1.1M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
BROWN ADVISORY INC $65,171,034 5,777,574 18.94% Shares
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $38,957,996 3,453,723 11.32% Shares
Think Investments LP $28,871,171 2,559,501 8.39% Shares
JANUS HENDERSON GROUP PLC $18,063,062 2,100,356 5.25% Shares
BlackRock, Inc. $15,770,703 1,398,112 4.58% Shares
JPMORGAN CHASE & CO $13,253,235 1,154,463 3.85% Shares
VANGUARD CAPITAL MANAGEMENT LLC $12,073,266 1,070,325 3.51% Shares
GOLDMAN SACHS GROUP INC $9,107,787 807,428 2.65% Shares
ROYCE & ASSOCIATES LP $8,900,371 789,040 2.59% Shares
Schonfeld Strategic Advisors LLC $8,673,077 768,890 2.52% Shares
BRIGADE CAPITAL MANAGEMENT, LP $7,511,352 665,900 2.18% Shares
RTW INVESTMENTS, LP $7,332,000 650,000 2.13% Shares
MILLENNIUM MANAGEMENT LLC $7,083,716 627,989 2.06% Shares
GEODE CAPITAL MANAGEMENT, LLC $7,066,966 626,318 2.05% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $7,053,046 625,270 2.05% Shares
ArrowMark Colorado Holdings LLC $6,791,113 602,049 1.97% Shares
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $6,768,000 600,000 1.97% Shares
Longaeva Partners L.P. $5,964,875 528,801 1.73% Shares
SILVERCREST ASSET MANAGEMENT GROUP LLC $5,271,584 467,339 1.53% Shares
STATE STREET CORP $5,178,964 459,128 1.51% Shares
FRANKLIN RESOURCES INC $5,059,565 448,543 1.47% Shares
VANGUARD GROUP INC $4,255,001 230,000 1.24% Shares
Prescott Group Capital Management, L.L.C. $4,027,524 357,050 1.17% Shares
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC $3,304,149 292,921 0.96% Shares
Point72 Asset Management, L.P. $3,169,263 280,963 0.92% Shares
Granahan Investment Management, LLC $2,968,400 263,156 0.86% Shares
READYSTATE ASSET MANAGEMENT LP $2,826,012 250,533 0.82% Shares
SEI INVESTMENTS CO $2,530,581 224,343 0.74% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $2,259,226 200,286 0.66% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $2,234,094 198,058 0.65% Shares
BECK MACK & OLIVER LLC $1,925,496 170,700 0.56% Shares
VANGUARD FIDUCIARY TRUST CO $1,842,814 163,370 0.54% Shares
NORTHERN TRUST CORP $1,832,108 162,421 0.53% Shares
FMR LLC $1,711,029 151,687 0.50% Shares
STATE OF WISCONSIN INVESTMENT BOARD $1,652,362 146,486 0.48% Shares
XTX Topco Ltd $1,550,662 137,470 0.45% Shares
SEVEN GRAND MANAGERS, LLC $1,240,800 110,000 0.36% Shares
Trexquant Investment LP $1,167,209 103,476 0.34% Shares
F/m Investments LLC $1,083,399 96,046 0.31% Shares
EMERALD MUTUAL FUND ADVISERS TRUST $1,083,399 96,046 0.31% Shares
AMERIPRISE FINANCIAL INC $944,824 83,761 0.27% Shares
FEDERATED HERMES, INC. $902,400 80,000 0.26% Shares
Squarepoint Ops LLC $901,656 79,934 0.26% Shares
AQR CAPITAL MANAGEMENT LLC $882,287 78,217 0.26% Shares
Ghisallo Capital Management LLC $846,000 75,000 0.25% Shares
UBS Group AG $755,174 66,948 0.22% Shares
Bank of New York Mellon Corp $709,388 62,889 0.21% Shares
CITADEL ADVISORS LLC $613,395 54,379 0.18% Shares
MORGAN STANLEY $438,374 38,863 0.13% Shares
RAYMOND JAMES FINANCIAL INC $410,400 36,383 0.12% Shares

Show all 104 institutional owners →

Company insiders 12 insiders · 5 officers · 8 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Caitlin Zulla Chief Executive Officer Dec. 12, 2025 A 129,728 0 0 $0
James Anthony Martin Chief Financial Officer Dec. 12, 2025 A 54,054 0 0 $0
James Edward Walker Jr. Principal Accounting Officer Feb. 25, 2026 A 17,346 0 0 $0
Julie Szeker Chief Legal Officer & Corp Sec Dec. 12, 2025 M 147,263 0 0 $0
Russell Stewart Chief Medical Officer Dec. 12, 2025 A 8,464 0 0 $0
Robert Louis Mittl Jr. Director June 10, 2026 A 19,358 0 0 $0
Matthew Lungren Director June 10, 2026 A 19,358 0 0 $0
Henry Lee Cooper Director June 10, 2026 A 19,358 1 0 $223,200
Bridget E Karlin Director June 10, 2026 A 19,358 0 0 $0
Molly Joseph Director June 10, 2026 A 46,385 0 0 $0
Brett Brodnax Director June 10, 2026 A 81,385 1 0 $253,750
Glenn A Eisenberg Director June 10, 2026 A 19,358 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 11 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 109,255 SH Aug. 19, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.01% 16,539 SH Aug. 19, 2026 Daily
IWM · iShares Trust 0.01% 508,197 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.01% 9,065 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 285,826 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 760,803 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 2,184 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.00% 72,308 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 179,670 SH Sept. 11, 2026 Daily
ISCB · iShares Trust · 1,092 SH Sept. 11, 2026 Daily
ISCV · iShares Trust · 5,411 SH Sept. 11, 2026 Daily

LMRI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 14 analysts BUY
Median target $17.50 +69.6%
6 42.9% Strong Buy
7 50.0% Buy
1 7.1% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

8 analysts · 2026-09-29

Mean target $17.62 +70.8%

← Below all targets Current price $10.32
Low$13.00 Mean$17.62 High$23.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
LMRI · · · · · ·
PNTG $975M 33.5 36.3% 3.1% 8.4% ·
OMDA $922M -45.1 53.2% -4.9% -5.8% 65.7%
INNV $1.61B -592.5 15.9% -0.26% -1.1% 23.0%
OPK · -4.2 -14.9% -37.2% -17.6% 33.9%
CSTL $1.15B -46.9 3.7% -7.0% -5.2% ·
FLGT $816M -84.7 13.8% -18.8% -5.4% 40.6%
GMRS · · · · · ·
CVS $100.87B 57.1 7.8% 0.44% 2.4% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 13, 2026